Published Online: Sunday, June 1, 2008

Nycomed US Inc recently completed its acquisition of Bradley Pharmaceuticals, a company focused on niche therapeutic markets in the United Sates. Nycomed will expand the line of dermatology products currently offered through its PharmaDerm Division. The company also expects that the purchase will provide an enhanced platform for in-licensing and copromotion of dermatology products.

Latest Articles
A pharmacy robber not only left his fingerprints behind at a pharmacy—he also dropped his wallet containing his identification as he made his escape.
Janssen Research and Development LLC has submitted a new drug application to the FDA for canagliflozin and metformin hydrochloride extended release (Invokamet XR).
Treating chronic pulmonary obstructive disease with both inhaled corticosteroids and long-acting bronchodilators remains controversial, but new evidence suggests that this controller combination could reduce mortality risk.
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares some fun tips on how to encourage patients who travel to come to your pharmacy for supplies.
Latest Issues